 |
Clara MattuResearcher (collaborator)BiographyDr. Clara Mattu is experienced post-doctoral researcher and Marie Curie fellow at Politecnico di Torino. She completed her Ph.D. in the group of Industrial Bioengineering at Politecnico di Torino. She has been visiting scientist at the Royal College of Surgeons in Ireland in 2011 and visiting postdoctoral fellow in the Department of Translational Imaging (2014) and in the Department of Nanomedicine (2016-2018) at the Houston Methodist Research Institute, and co-founder of the spin-off Company Geltis. In 2012, she was awarded the Italian Working Capital National Innovation grant (30.000 €) to perform research on injectable hydrogels for drug delivery. In 2015, she received the prestigious Marie Curie International Outgoing Fellowship from the European Commission to design hybrid drug delivery systems for intra-cranial treatment of brain tumors. Her research interests are highly super-disciplinary, and span from biomedical polymer synthesis and characterization to cancer nanomedicine. Through multiple research experiences, Dr. Mattu has acquired diversified skills in polymer synthesis, tissue engineering, molecular biology, tissue processing, animal protocols and in vivo testing. She is currently lecturer at Politecnico di Torino for the course "Hands-on training in biomedical nanotechnologies and advanced therapies". Since 2019, she has become tenure-track researcher at Politecnico di Torino. Dr. Mattu has supervised several undergraduate and graduate students, authored 28 publications, more than 35 conference proceedings, 3 book chapters, and 1 patent. Clara Mattu |